CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-02 | MEIER RICHARD A Director | Sale | −18 | $82.12 | $1K | 104,014 |
| 2022-05-02 | MEIER RICHARD A Director | Exercise or conversion · Stock Option (Right to buy Common Stock) | −8,500 | 0 | ||
| 2022-05-02 | Davis George Eric EVP, Chief Legal Officer | Exercise or conversion | +15,347 | $37.46 | $575K | 81,686 |
| 2022-05-02 | Davis George Eric EVP, Chief Legal Officer | Sale | −15,347 | $80.38 | $1.2M | 66,339 |
| 2022-05-02 | Davis George Eric EVP, Chief Legal Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −15,347 | 0 | ||
| 2022-04-29 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Grant or award | +340 | $62.41 | $21K | 55,417 |
| 2022-04-29 | BIENAIME JEAN JACQUES Chief Executive Officer | Grant or award | +341 | $62.41 | $21K | 335,324 |
| 2022-04-29 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award | +243 | $62.41 | $15K | 52,299 |
| 2022-04-29 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +340 | $62.41 | $21K | 38,639 |
| 2022-04-29 | Davis George Eric EVP, Chief Legal Officer | Grant or award | +341 | $62.41 | $21K | 66,339 |
Page 23 of 23 · 450 trades